Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Anemia 4Neoplasms 2Leukemia, Myeloid, Acute 2Uterine Cervical Neoplasms 1Transfusion Reaction 1Thalassemia 1Patient Participation 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia 1Hemorrhage 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bone Marrow Failure Disorders 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

Cytarabine 358Cyclophosphamide 241Azacitidine 214fludarabine phosphate 199venetoclax 198fludarabine 196Busulfan 148Decitabine 132Mycophenolic Acid 123Whole-Body Irradiation 122Peripheral Blood Stem Cell Transplantation 118Tacrolimus 115Granulocyte Colony-Stimulating Factor 104Idarubicin 100Filgrastim 100Melphalan 89Cyclosporine 89Methotrexate 83Daunorubicin 76Antilymphocyte Serum 75Etoposide 73Mitoxantrone 67Clofarabine 67Gemtuzumab 59Stem Cell Transplantation 55Thiotepa 51Cladribine 46Specimen Handling 45Injections 45thymoglobulin 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myeloid, Acute × Blood Transfusion × Clear all
NCT07062250 2025-07-14

HOME-BLOOD

Rigshospitalet, Denmark

Phase NA Recruiting
15 enrolled
Other hematologic neoplasm

Patient Participation, Leukemia, Myeloid, Acute

NCT02845232 2016-07-27

Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly

Hospices Civils de Lyon

Completed
214 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡